These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 15562207)

  • 1. Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention.
    Lim HS; Blann AD; Chong AY; Freestone B; Lip GY
    Diabetes Care; 2004 Dec; 27(12):2918-24. PubMed ID: 15562207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis.
    Lim HS; Lip GY; Blann AD
    Atherosclerosis; 2005 May; 180(1):113-8. PubMed ID: 15823283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.
    Mohan JS; Lip PL; Blann AD; Bareford D; Lip GY
    Br J Ophthalmol; 2005 Jul; 89(7):815-9. PubMed ID: 15965157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of Angiopoietin-2 and vascular endothelial growth factor as markers of diabetic nephropathy onset in Egyptians diabetic patients with non-albuminuric state.
    Aly MH; Arafat MA; Hussein OA; Elsaid HH; Abdel-Hammed AR
    Diabetes Metab Syndr; 2019; 13(2):1623-1627. PubMed ID: 31336531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
    Nadar SK; Blann A; Beevers DG; Lip GY
    J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of atorvastatin on circulating CD34+/CD133+/ CD45- progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus.
    Jaumdally RJ; Goon PK; Varma C; Blann AD; Lip GY
    J Intern Med; 2010 Apr; 267(4):385-93. PubMed ID: 19754853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Angiogenic Mediators in Patients with Moderate and Severe von Willebrand Disease: A Multicentre Cross-Sectional Study.
    Groeneveld DJ; Sanders YV; Adelmeijer J; Mauser-Bunschoten EP; van der Bom JG; Cnossen MH; Fijnvandraat K; Laros-van Gorkom BAP; Meijer K; Lisman T; Eikenboom J; Leebeek FWG
    Thromb Haemost; 2018 Jan; 118(1):152-160. PubMed ID: 29304535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of multi-factorial intervention on plasma von Willebrand factor, soluble E-selectin and tissue factor in diabetes mellitus: implications for atherosclerotic vascular disease.
    Lim HS; Chong AY; Freestone B; Blann AD; Lip GY
    Diabet Med; 2005 Mar; 22(3):249-55. PubMed ID: 15717870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of circulating angiogenic factors in diabetic kidney disease].
    Martynov SA; Shestakova MV; Kutyrina IM; Il'in AV; Arbuzova MI; Dedov II
    Vestn Ross Akad Med Nauk; 2013; (2):35-42. PubMed ID: 23819327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.
    Lee KW; Lip GY; Blann AD
    Circulation; 2004 Oct; 110(16):2355-60. PubMed ID: 15302795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of Serum 25(OH)VD3, HIF-1α, VEGF, vWf, and IGF-1 and Their Correlation in Type 2 Diabetes Patients with Different Urine Albumin Creatinine Ratio.
    Shao Y; Lv C; Yuan Q; Wang Q
    J Diabetes Res; 2016; 2016():1925424. PubMed ID: 27069929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is soluble CD40 ligand a mediator of angiogenesis in patients with coronary artery disease?
    Lim HS; Tayebjee MH; Tan KT; Patel JV; Macfadyen RJ; Lip GY
    Thromb Res; 2008; 122(3):307-13. PubMed ID: 18054068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
    Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY
    Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-19 and angiopoietin-2 can enhance angiogenesis of diabetic complications.
    Li L; Yu ZH; Qian L; Xu JY; Liu F; Zhao GC; Zhang L; Gu HM; Zhang SJ; Meng J
    J Diabetes Complications; 2016 Mar; 30(2):386-7. PubMed ID: 26657726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-2 is associated with albuminuria and microinflammation in chronic kidney disease.
    Chang FC; Lai TS; Chiang CK; Chen YM; Wu MS; Chu TS; Wu KD; Lin SL
    PLoS One; 2013; 8(3):e54668. PubMed ID: 23469160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal soluble CD40 ligand and C-reactive protein concentrations in hypertension: relationship to indices of angiogenesis.
    Patel JV; Lim HS; Nadar S; Tayebjee M; Hughes EA; Lip GY
    J Hypertens; 2006 Jan; 24(1):117-21. PubMed ID: 16331109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure.
    Chong AY; Caine GJ; Freestone B; Blann AD; Lip GY
    J Am Coll Cardiol; 2004 Feb; 43(3):423-8. PubMed ID: 15013125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained Elevation of Vascular Endothelial Growth Factor and Angiopoietin-2 Levels After Transcatheter Aortic Valve Replacement.
    Ben-Shoshan J; Steinvil A; Arbel Y; Topilsky Y; Barak L; Entin-Meer M; Levy R; Schwartz AL; Keren G; Finkelstein A; Banai S
    Can J Cardiol; 2016 Dec; 32(12):1454-1461. PubMed ID: 27720271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenic factors in atrial fibrillation: a possible role in thrombogenesis?
    Freestone B; Chong AY; Lim HS; Blann A; Lip GY
    Ann Med; 2005; 37(5):365-72. PubMed ID: 16179272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma angiopoietin-2 outperforms other markers of endothelial injury in prognosticating pediatric ARDS mortality.
    Zinter MS; Spicer A; Orwoll BO; Alkhouli M; Dvorak CC; Calfee CS; Matthay MA; Sapru A
    Am J Physiol Lung Cell Mol Physiol; 2016 Feb; 310(3):L224-31. PubMed ID: 26660787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.